Excipients, raw materials & intermediates

F2G raises $100 million to combat innovation 'paucity' in antifungals

17-Sep-2024 By Jonathan Smith

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.

Psychedelic drug investments surge in 2024: Key startups raising funds and closing deals

16-Jul-2024 By Clara Rodriguez Fernandez

Psychedelic therapeutics have rapidly gained popularity in the pharma industry in a matter of just a few years. Here are five psychedelic drug discovery startups that have received investment this year.

Ketaki Patwardhan - from experiments with her dad to excipients and manufacturing at Roquette

11-Jul-2024 By Liza Laws

Ketaki Patwardhan, a global technical developer at Roquette, has built a remarkable career in the pharmaceutical industry by leveraging her curiosity and passion for science.

dsm-firmenich launches CBtru, revolutionizing CBD drug development with enhanced bioavailability

09-Jul-2024 By Liza Laws

dsm-firmenich has announced the launch of CBtru – an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.

Esteve invests €100 million in Spanish API manufacturing muscle

02-Jul-2024 By Jonathan Smith

The Spanish company Esteve Pharmaceuticals is building a manufacturing unit in its Girona plant with the aim to expand its production of active pharmaceutical ingredients (APIs).

Is Combogesic IV revolutionizing pain management in the US healthcare market?

11-Jun-2024 By Liza Laws

Hikma Pharmaceuticals PLC has made a significant announcement, marking the US launch of Combogesic IV, an intravenous, opioid-free pain relief medication providing a multimodal approach to managing pain in adults.

Roquette's US innovation center marks first year of pharmaceutical advancements

06-Jun-2024 By Liza Laws

As Roquette's US Innovation Center marks its first anniversary, Roquette took the opportunity to reflect on its interesting journey and achievements over the past year.

Roquette solving toughest drug development challenges with new capsules

14-May-2024 By Liza Laws

Roquette, a global leader in plant-based ingredients and a key provider of pharmaceutical and nutraceutical excipients, announced today (May 14) the launch of its innovative Lycagel Flex hydroxypropyl pea starch premix for softgel capsules.

Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

19-Apr-2024 By Liza Laws

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

Vox Pop Pharma - companies keen to find alternatives to animal testing - read their views

19-Apr-2024 By Liza Laws

Earlier this week, Charles River Laboratories International, Inc. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.

Production of tree-saving transformative vaccine adjuvant with in-lab plants

17-Apr-2024 By Liza Laws

During DCAT this year, CEO Gaston Salinas from Botanical Solution Inc., (BSI), sat down with Liza Laws, the senior editor of OSP and BPR to discuss his company’s pioneering work in revolutionizing vaccine adjuvant production.

DCAT 2024

Bormioli Pharma leading the way with sustainable pharmaceutical packaging

17-Apr-2024 By Liza Laws

Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.

Adragos Pharma - poised to make a lasting impact in the pharmaceutical industry

11-Apr-2024 By Liza Laws

Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and...

Roquette snaps up IFF Pharma Solutions for $2.85 billion

20-Mar-2024 By Isabel Cameron

Roquette has acquired the pharma solutions division at International Flavors & Fragrances, in a deal up to $2.85 billion.

DCAT 2024

What are the global pharma giants' goals at DCAT 2024? A written roundtable reveals all

19-Mar-2024 By Liza Laws

The curtains have risen on DCAT 2024 in the vibrant heart of New York City, and leading pharmaceutical companies from around the world have converged for a week of innovation, collaboration, and strategic dialogue.

Clerkenwell Health calling for volunteers with PTSD to trial new psychoactive drug

05-Mar-2024 By Liza Laws

Clerkenwell Health, a company that delivers clinical trials for the treatment of complex mental health volunteers for trials into the use of psychoactive medications for treating PTSD, is in search of 40 ex-military volunteers.

Webinar: Innovations in drug delivery - tune in and join our excellent panel

27-Feb-2024 By Liza Laws

As the landscape of healthcare continues to evolve, so too does the field of drug delivery.

Roquette and Qualicaps combine to expand global footprint

08-Dec-2023 By Liza Laws

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Piramal Pharma has launched a high-throughput screening facility

06-Dec-2023 By Liza Laws

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

SSNL Manufacturing updates

Q&A: Univar Solutions - the importance and challenges of distributing and sourcing pharma ingredients

06-Dec-2023 By Liza Laws

From its origins in ancient military time where the Romans and Greeks used logistics and distribution channels to supply their armies, to today's challenges with the supply chain for pharma ingredients, we enjoyed putting some questions to Univar...

Amcor launches new sustainable medical laminates solutions

08-Nov-2023 By Liza Laws

Amcor has taken a significant step towards sustainability by launching the next generation of its medical laminates solutions.

IFF to launch latest well-characterized biopolymer Methanova at CPHI

18-Oct-2023 By Liza Laws

IFF’s Pharma Solutions division is poised to introduce new products and investments at this year's CPHI being held in Barcelona. OSP was lucky enough to catch up with them before the event starting next week.

Bioiberica excited to welcome pharma stakeholders to its hometown for CPHI

18-Oct-2023 By Liza Laws

Bioiberica says the excitement for this year’s CPHI has been ‘taken up a notch’ as the company looks forward to welcoming both old and new customers to its hometown, Barcelona.

'Extremely important outcome for Alzheimer's patients' following Synaptogenix trial

16-Oct-2023 By Liza Laws

Patients with severe Alzheimer's Disease (AD) showed no cognitive decline throughout a ten-month trial while being treated with Bryostatin-1.

Health authority approval given to Omya for API production

27-Apr-2023 By Liza Laws

Swiss company Omya’s production site in Kemalpaşa, Turkey, has gained health authority approval to produce GMP-compliant pharmaceutical ingredients.

Roquette opens $25m US oral dosage innovation center

24-Apr-2023 By Ben Hargreaves

The French company announces the opening of its facility, and the hiring of research scientists and formulation specialists that will staff the site.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

CPI and 24 partners open £88m manufacturing innovation center

06-Dec-2022 By Ben Hargreaves

The collaborators unveil the facility after combing ideas from pharma and technology sectors to develop more sustainable manufacturing processes.

Lonza expanding dry powder inhalation capabilities at Florida site

01-Sep-2022 By Jenni Spinner

In response to rising demand for inhalable treatments geard toward respiratory conditions, the company is adding capabilities and capacity at its Tampa site.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Piramal Pharma Solutions opens doors on API production plant

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization's active pharmaceutical ingredient manufacturing operation is located at its site in Aurora, Canada.

bio 2022

Pandemic highlights need for supply chain visibility, partnerships

14-Jun-2022 By Jenni Spinner

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.

CPHI North America

Future drugs will need novel excipients: IPEC

04-May-2022 By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.

CPhI North America 2022

Continuous manufacturing adoption continues to rise: Pharmatech

04-May-2022 By Jenni Spinner

An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.

Proposed bill aims to encourage US pharmaceutical manufacturing

03-May-2022 By Jenni Spinner

Introduced by two Republican Congressmen, the American Made Medicine Act is intended to boost domestic drug manufacturing and create jobs in the sector.

Inke to triple capacity for inhalation API manufacturing

20-Apr-2022 By Jenni Spinner

The maker of active pharmaceutical ingredients for inhaled treatments is investing €9m ($9.8m USD) to expand its manufacturing plant in Barcelona, Spain.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

DFE Pharma, Harro Höfliger, and Sterling forge respiratory partnership

06-Apr-2022 By Jenni Spinner

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

Pharma supply chain could learn from the food industry: Rephine

04-Apr-2022 By Jenni Spinner

An executive from Rephine Catena discusses how pharmaceutical companies dealing with supply chain challenges could draw lessons from the food industry.

Tech Innovations: March 2022

17-Mar-2022 By Jenni Spinner

The latest news on software, manufacturing solutions, partnerships, and more includes IQVIA, TFF Pharmaceuticals, Quotient Sciences and other key companies.

People on the Move: March 2022

03-Mar-2022 By Jenni Spinner

This month’s announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

Expect higher prices, limited availability of materials in 2022: CPhI Worldwide

06-Jan-2022 By Jenni Spinner

In a report outlining predictions for the coming year, the organization advises industry professionals to brace themselves for supply chain challenges.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Resilience, collaboration can drive pharma innovation: IFF

03-Jan-2022 By Jenni Spinner

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

Roquette plans to open doors of new US innovation center

08-Dec-2021 By Jenni Spinner

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

Tech Innovations: November 2021

18-Nov-2021 By Jenni Spinner

This month’s launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

From the show floor: Exhibitors at CPhI Worldwide 2021

03-Nov-2021 By Rachel Arthur

CPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.

CPhI Worldwide

Expert offers prescription for improving medicine production in Europe

02-Nov-2021 By Jenni Spinner

A leader from Medicines for Europe will share with CPhI Worldwide attendees a look at medicine production and offer solutions for elevating the industry.